Beta-Blockers are Associated with Decreased In-Hospital Mortality and Stroke in Acute Decompensated Heart Failure: Findings from a Retrospective Analysis of a 22-Year Registry in the Middle East (1991-2013).

Autor: Abi Khalil C, Al Suwaidi J; Adult Cardiology Department. Heart Hospital, Hamad Medical Corporation, Doha, Qatar. jalsuwaidi@hamad.qa., Singh R, Asaad N, Abushahba G, Kunju U, Al Qahtani A, AlBinali HA
Jazyk: angličtina
Zdroj: Current vascular pharmacology [Curr Vasc Pharmacol] 2017; Vol. 15 (1), pp. 77-83.
DOI: 10.2174/1570161114666160822155440
Abstrakt: Background: Beta-blockers reduce mortality in chronic heart failure.
Objectives: To study intra-hospital mortality and adverse cardiovascular (CV) outcomes in relation to beta-blockade therapy in acute decompensated heart failure.
Methods: We retrospectively analyzed a 22-year registry of acute decompensated heart failure (ADHF) in the Middle East.
Results: Out of the total 8066 patients admitted for ADHF, 1242(15.4%) were on beta-blockers on admission. Among those, beta-blockers were discontinued in 26.5%. Despite the existence of less CV comorbidities in patients not treated by beta-blockers, in-hospital mortality and stroke/transient ischemic attacks rates were higher in those patients compared with patients on beta-blockers on admission (14.4 vs. 3.6%, p=0.001, 0.6 vs. 0.1%, p=0.02; respectively). Additionally, continuation of beta-blockers during acute decompensation was associated with less mortality risk (p=0.001). The use of beta-blockers on admission and discharge increased significantly with time whereas in-hospital mortality decreased (p=0.001). Nevertheless, admission year was not a predictor of reduced mortality in patients treated with beta-blockers on admission (OR 0.93, 95% CI [0.56-1.54], p=0.77).
Conclusion: Previous beta-blockade therapy in patients presenting with ADHF decreases intra-hospital mortality and the incidence of CV events and stroke/transient ischemic attacks. Moreover, nonwithdrawal of beta-blockers during hospitalization has a favorable outcome.
Databáze: MEDLINE